HOUSTON -- A photoplethysmography (PPG)-based artificial intelligence (AI) system for detection of obstructive sleep apnea (OSA) showed no evidence of bias in performance based on skin color, ...
Sunrise Group, a pioneer in medical device innovation and sleep care, today announced results from the SUNSAS clinical study, now published in The Lancet Regional Health – Europe, a leading ...
On Wednesday, Incannex Healthcare Inc. (NASDAQ:IXHL) released topline results from its RePOSA Phase 2 clinical trial evaluating IHL-42X, a novel oral drug candidate for obstructive sleep apnea (OSA), ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...
Today, Sunrise Group, a pioneer in medical device innovation and sleep care, announced that the new generation of its home sleep test, Sunrise Air, has officially received FDA clearance. This ...
Introduction: The cardiovascular system (CVS) is heavily influenced by the autonomic nervous system. Additionally, there is a functional alteration during the various stages of sleep. In nonrapid eye ...
People whose symptoms make it highly likely they have obstructive sleep apnea (OSA) can safely start treatment without first obtaining a confirmatory diagnosis in a sleep laboratory. So concludes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results